FDA rolls out long-awaited proposal to overhaul diagnostics regulation

Lia DeGroot

The FDA on Friday unveiled a long-awaited proposed rule that aims to overhaul how the agency regulates diagnostic tests, bringing thousands of new tests under …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA rolls out long-awaited proposal to overhaul diagnostics regulation

Lia DeGroot

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

FDA rolls out long-await­ed pro­pos­al to over­haul di­ag­nos­tics reg­u­la­tion

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

FDA rolls out long-awaited proposal to overhaul diagnostics regulation